PL1809662T3 - Dezamidowany interferon-beta - Google Patents

Dezamidowany interferon-beta

Info

Publication number
PL1809662T3
PL1809662T3 PL05818235T PL05818235T PL1809662T3 PL 1809662 T3 PL1809662 T3 PL 1809662T3 PL 05818235 T PL05818235 T PL 05818235T PL 05818235 T PL05818235 T PL 05818235T PL 1809662 T3 PL1809662 T3 PL 1809662T3
Authority
PL
Poland
Prior art keywords
beta
deamidated
interferon
native
protein
Prior art date
Application number
PL05818235T
Other languages
English (en)
Polish (pl)
Inventor
Kenji Furuya
Deborah Johnson-Jackson
Diana Tierra Ruscio
Original Assignee
Novartis Vaccines & Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Vaccines & Diagnostics Inc filed Critical Novartis Vaccines & Diagnostics Inc
Publication of PL1809662T3 publication Critical patent/PL1809662T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/565—IFN-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
PL05818235T 2004-11-10 2005-11-10 Dezamidowany interferon-beta PL1809662T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US62683704P 2004-11-10 2004-11-10
PCT/US2005/040758 WO2006053134A2 (en) 2004-11-10 2005-11-10 Deamidated interferon-beta
EP05818235A EP1809662B1 (en) 2004-11-10 2005-11-10 Deamidated interferon-beta

Publications (1)

Publication Number Publication Date
PL1809662T3 true PL1809662T3 (pl) 2009-07-31

Family

ID=36337216

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05818235T PL1809662T3 (pl) 2004-11-10 2005-11-10 Dezamidowany interferon-beta

Country Status (16)

Country Link
US (2) US7595040B2 (https=)
EP (1) EP1809662B1 (https=)
JP (1) JP4891250B2 (https=)
KR (1) KR101330626B1 (https=)
CN (1) CN101056890B (https=)
AT (1) ATE415421T1 (https=)
AU (1) AU2005304486B2 (https=)
BR (1) BRPI0517697A (https=)
CA (1) CA2587061C (https=)
DE (1) DE602005011321D1 (https=)
ES (1) ES2318575T3 (https=)
MX (1) MX2007004990A (https=)
PL (1) PL1809662T3 (https=)
PT (1) PT1809662E (https=)
RU (1) RU2404190C2 (https=)
WO (1) WO2006053134A2 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030190307A1 (en) 1996-12-24 2003-10-09 Biogen, Inc. Stable liquid interferon formulations
WO2008020968A2 (en) * 2006-08-08 2008-02-21 Novartis Ag Recombinant interferon-beta with enhanced biological activity
MX2009011870A (es) 2007-05-02 2009-11-12 Ambrx Inc Polipeptidos de interferon beta modificados y usos de los mismos.
US8273561B2 (en) * 2007-10-05 2012-09-25 Nuron Biotech, Inc. High pressure treatment of aggregated interferons
ES2736503T3 (es) * 2014-04-04 2020-01-02 Ares Trading Sa Nuevos análogos de la proteína IFN beta
RU2739261C1 (ru) * 2019-12-31 2020-12-22 Федеральное государственное бюджетное учреждение науки институт биоорганической химии им. академиков М.М. Шемякина и Ю.А. Овчинникова Российской академии наук (ИБХ РАН) Способ количественного определения антипролиферативной активности интерферона-бета человека

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4588585A (en) 1982-10-19 1986-05-13 Cetus Corporation Human recombinant cysteine depleted interferon-β muteins
US4737462A (en) 1982-10-19 1988-04-12 Cetus Corporation Structural genes, plasmids and transformed cells for producing cysteine depleted muteins of interferon-β
US4959314A (en) 1984-11-09 1990-09-25 Cetus Corporation Cysteine-depleted muteins of biologically active proteins
GB9111902D0 (en) 1991-06-03 1991-07-24 Glaxo Group Ltd Chemical compounds
US20030190307A1 (en) 1996-12-24 2003-10-09 Biogen, Inc. Stable liquid interferon formulations
JP4878664B2 (ja) 1996-12-24 2012-02-15 バイオジェン・アイデック・エムエイ・インコーポレイテッド 安定な液体インターフェロン処方物
US6696423B1 (en) 1997-08-29 2004-02-24 Biogen, Inc. Methods and compositions for therapies using genes encoding secreted proteins such as interferon-beta
CA2304808C (en) * 1997-09-23 2011-03-22 Michael Tschope Liquid interferon-.beta. formulations
ES2355055T3 (es) 1999-07-28 2011-03-22 Genentech, Inc. Composiciones y procedimientos para el tratamiento de tumores.
ES2180416B1 (es) 2001-03-12 2004-06-01 BIOTOOLS BIOTECHNOLOGICAL & MEDICAL LABORATORIES, S.A. Procedimiento para la preparacion de mezclas de reaccion estabilizadas, total o parcialmente desecadas, que comprenden, al menos, una enzima, mezclas de reaccion y kits que las contienen.
AR034749A1 (es) * 2001-07-09 2004-03-17 Schering Ag Formulaciones de interferon beta humano
RU2216345C1 (ru) * 2002-03-21 2003-11-20 Закрытое Акционерное Общество "Биокад" Средство, обладающее иммуномодулирующим, противовирусным, противобактериальным, регенерирующим, репаративным, мембрано- и гепатопротекторным действием
KR100541850B1 (ko) * 2003-03-31 2006-01-11 삼성정밀화학 주식회사 인간 인터페론-베타 변이체 및 그의 제조방법

Also Published As

Publication number Publication date
RU2404190C2 (ru) 2010-11-20
ATE415421T1 (de) 2008-12-15
US7595040B2 (en) 2009-09-29
WO2006053134A3 (en) 2006-08-31
RU2007121515A (ru) 2008-12-20
EP1809662B1 (en) 2008-11-26
ES2318575T3 (es) 2009-05-01
EP1809662A2 (en) 2007-07-25
WO2006053134A2 (en) 2006-05-18
BRPI0517697A (pt) 2008-10-14
PT1809662E (pt) 2009-02-26
MX2007004990A (es) 2007-06-14
KR101330626B1 (ko) 2013-11-18
JP2008519769A (ja) 2008-06-12
JP4891250B2 (ja) 2012-03-07
CA2587061A1 (en) 2006-05-18
CA2587061C (en) 2011-08-16
AU2005304486A1 (en) 2006-05-18
AU2005304486B2 (en) 2011-08-11
CN101056890A (zh) 2007-10-17
DE602005011321D1 (de) 2009-01-08
US20090263355A1 (en) 2009-10-22
KR20070084559A (ko) 2007-08-24
US20060120998A1 (en) 2006-06-08
CN101056890B (zh) 2012-05-09

Similar Documents

Publication Publication Date Title
ATE430197T1 (de) Fibroblasten wachstumsfaktor-ähnliche polypeptide
NO2017028I2 (no) eftrenonacog alfa eller et biotilsvarende legemiddel ihht Artikkel 10(4) av Directive 2001/83/EC, som beskyttet av basispatentet.
DE602004012424D1 (de) Homogene herstellungen von il-29
ATE540973T1 (de) Zusammensetzungen und verfahren zur verwendung von mgd-cdf zur krankheitsbehandlung
ATE417595T1 (de) Keratin-bindende polypeptide
BRPI0416683A (pt) muteìna de fator de crescimento de fibroblasto de humano 21 (fgf-21), ou um seu peptìdeo biologicamente ativo, polinucleotìdeo, vetor de expressão, célula hospedeira, processo para produzir um polipeptìdeo, composição farmacêutica, método para tratar um paciente, e, uso da muteìna fgf-21
NZ279963A (en) Human tissue inhibitor of metalloproteinase-4 (timp-4) and dna (rna) encoding polypeptide which may be derived from atcc 75946
WO2002044320A3 (en) Human elongase genes and uses thereof
MXPA05008704A (es) Proteinas de fusion de muteinas de interferon alfa con propiedades mejoradas.
PL1809662T3 (pl) Dezamidowany interferon-beta
MX2009001348A (es) Interferon-beta recombinante con actividad biologica mejorada.
WO2008041014A3 (en) Interferon- alpha constructs for use in the treatment of diseases characterised by abnormal cell proliferation such as cancer
Ketscher et al. ISG15 uncut: Dissecting enzymatic and non-enzymatic functions of USP18 in vivo
NZ562436A (en) Toll-like receptor 14 (TLR14) and use thereof
DE60335665D1 (de) Mittel zur förderung der hautkollagenproduktion
MX2009007248A (es) Peptidos bio-activos cortos para modulacion celular e inmunologica.
ES2088911T3 (es) Gen de la proteasa i de achromobacter y el producto de este gen.
WO2002000878A3 (fr) Dynamine mitochondriale humaine msp1, ses isoformes msp1-x, et leur utilisation en therapeutique
ATE420890T1 (de) Isoleucyl-valyl-threonyl-asparaginyl-threonyl- threonin (ivtntt) enthaltende biologisch wirksame peptide
TW200722104A (en) Low-toxicity, long-circulating human interferon-α analogs
ATE538806T1 (de) Peptide mit spezifischem sitz in herzgefässen und verwandte konjugate und verfahren
WO2006025995A3 (en) Compositions and methods using md-2 mutants and chimeric proteins
DE602004019556D1 (de) Neues plexin-polypeptid, dieses codierende dna und verwendung davon
WO2003099995A3 (en) Murine ortholog of the human disrupted-in-schizophrenia 1 gene
ATE284965T1 (de) Verwendung des cd24-markergens zur selektion von keratinozyten die mit einem exogenen sekvens transformiert sind